Employment Agreement - Nanogen Inc. and Vera P. Pardee, Esq.
EMPLOYMENT AGREEMENT
THIS AGREEMENT, effective as of November 1, 2000, is made by and
between NANOGEN, INC., a Delaware corporation (hereinafter the "Company"), and
VERA P. PARDEE, Esq. (hereinafter "Executive").
RECITALS
WHEREAS, the Company and Executive wish to set forth in this Agreement
the terms and conditions under which Executive will continue to be employed by
the Company; and
WHEREAS, the Company wishes to be assured that Executive will be
available to the Company for an additional three (3) years after November 1,
2000.
NOW, THEREFORE, the Company and Executive, in consideration of the
mutual promises set forth herein, agree as follows:
ARTICLE I.
TERM OF AGREEMENT
A. COMMENCEMENT DATE. The terms of this Agreement shall govern
Executive's employment with the Company from November 1, 2000 ("Commencement
Date") and this Agreement shall expire after a period of three (3) years from
the Commencement Date, unless terminated earlier pursuant to Article 6.
B. RENEWAL. The term of this Agreement shall be automatically
renewed for successive, additional three (3) year terms unless either party
delivers written notice to the other at least ninety (90) days prior to the
expiration date of this Agreement of an intention to terminate this Agreement or
to renew it for a term of less than three (3) years but not less than (1) year.
If the term of this Agreement is renewed for a term of less than three (3)
years, then thereafter the term of this Agreement shall be automatically renewed
for successive, additional identical terms unless either party delivers a
written notice to the other at least ninety (90) days prior to a termination
date of this Agreement of an intention to terminate this Agreement or to renew
it for a different term of not less than one (1) year. Any renewal bonus will be
negotiated as mutually agreed to at the time of any renewal of this Agreement.
If this Agreement is not renewed at the end of any term hereof by the
Company for any reason except death, disability or retirement of Executive,
notwithstanding anything herein elsewhere contained, Executive shall be paid his
salary, as provided for in Section 3.A hereof, and receive the other benefits
applicable under Article 4 hereof, for an additional six months after the
termination date hereof.
-1
<PAGE>
ARTICLE II.
EMPLOYMENT DUTIES
A. TITLE/RESPONSIBILITIES. Executive hereby accepts employment
with the Company pursuant to the terms and conditions hereof. Executive agrees
to serve the Company in the position of Vice President, Assistant General
Counsel and Secretary. Executive shall have the powers and duties commensurate
with such position, including but not limited to, hiring personnel necessary (in
the judgment of the Board of Directors) to carry out the responsibilities for
such position.
B. FULL TIME ATTENTION. Executive shall devote her best efforts
and her full business time and attention to the performance of the services
customarily incident to such office and to such other services as the Board may
reasonably request.
C. OTHER ACTIVITIES. Except upon the prior written consent of the
Board of Directors, Executive shall not during the period of employment engage,
directly or indirectly, in any other business activity (whether or not pursued
for pecuniary advantage) that is or may be competitive with, or that might place
her in a competing position to that of the Company or any other corporation or
entity that directly or indirectly controls, is controlled by, or is under
common control with the Company (an "Affiliated Company"), provided that
Executive may own less than two percent of the outstanding securities of any
such publicly traded competing corporation.
ARTICLE III.
COMPENSATION
A. BASE SALARY. Executive shall receive a Base Salary at an
annual rate of one hundred seventy five thousand dollars ($175,000), payable in
accordance with the Company's customary payroll practices. The Company's Board
of Directors shall provide Executive with annual performance reviews, and,
thereafter, Executive shall be entitled to such Base Salary as the Board of
Directors may from time to time establish in its sole discretion.
B. ACHIEVEMENT BONUS. The Company shall pay Executive an
Achievement Bonus of up to 50% of Executive's Base Salary annually based upon
achievement by the Company of its corporate goals as established and determined
by the Board of Directors annually and for other achievements by the Company or
the Executive during the year as approved by the Compensation Committee. The
Board of Directors or Compensation Committee, as applicable, shall, in their
respective sole discretion, determine whether such corporate or other goals have
been attained or other achievements have occurred.
C. TRANSACTION BONUS. In addition, in the event of a transaction
involving a Change in Control, in a transaction approved by the Company's Board
of Directors, which transaction results in the receipt by the Company's
stockholders of consideration with a value representing, in the sole judgment of
the Board of Directors, a significant premium over the average of the
-2
<PAGE>
closing prices per share of the Company's common stock as quoted on the Nasdaq
National Market for 20 trading days ending one day prior to the public
announcement of such transaction (a "Change in Control Transaction"), Executive
shall be paid a Transaction Bonus at the closing of such a transaction in the
amount equal to one (1) times 50% of Executive's Base Salary in effect
immediately preceding the closing of such a transaction. Executive shall also be
paid said Transaction Bonus if the Company enters into a transaction approved by
the Board of Directors which is not a Change in Control Transaction, but which,
nonetheless, involves a significant change in the ownership of the Company or
the composition of the Board of Directors of the Company, or which results in
receipt of a premium for the Company's stockholders (a "Significant Event"). In
the event Executive receives a Transaction Bonus, no Achievement Bonus will be
paid to Executive in the year in which such Transaction Bonus is paid.
If the Company enters into a transaction which is a Change in Control
Transaction, then all of the Executive's stock options granted effective as of
or prior to November 1, 2000 shall become exercisable in full and all of the
shares of the common stock of the Company awarded to Executive under the
Company's 1997 Stock Incentive Plan shall become fully vested. If the Company
enters into a transaction which is not a Change in Control Transaction but which
is a Significant Event, then the Board of Directors may, in its sole discretion,
determine that all, or a portion, of the Executive's stock options granted
effective on or prior to November 1, 2000 shall become exercisable in full and
all, or a portion, of the shares of the common stock of the Company awarded to
Executive under the Company's 1997 Stock Incentive Plan shall become fully
vested.
D. WITHHOLDINGS. All compensation and benefits to Executive
hereunder shall be subject to all federal, state, local and other withholdings
and similar taxes and payments required by applicable law.
ARTICLE IV.
EXPENSE ALLOWANCES AND FRINGE BENEFITS
A. VACATION. Executive shall be entitled to three (3) weeks, plus
one (1) additional day for each completed year of employment with the Company,
of annual paid vacation during the term of this Agreement.
B. BENEFITS. During the term of this Agreement, the Company shall
also provide Executive with the usual health insurance benefits it generally
provides to its other senior management employees, other than life insurance
(which shall be paid directly by Executive). As Executive becomes eligible in
accordance with criteria to be adopted by the Company, the Company shall provide
Executive with the right to participate in and to receive benefits from
accident, disability, medical, pension, bonus, stock, profit-sharing and savings
plans and similar benefits made available generally to employees of the Company
as such plans and benefits may be adopted by the Company, provided that
Executive shall during the term of this Agreement be entitled to receive at a
minimum standard medical and dental benefits similar to those typically afforded
to Chief Executive Officers in similar sized biotechnology companies, excluding
life
-3
<PAGE>
insurance. The amount and extent of benefits to which Executive is entitled
shall be governed by the specific benefit plan as it may be amended from time to
time.
C. BUSINESS EXPENSE REIMBURSEMENT. During the term of this
Agreement, Executive shall be entitled to receive proper reimbursement for all
reasonable out-of-pocket expenses incurred by her (in accordance with the
policies and procedures established by the Company for its senior executive
officers) in performing services hereunder, provided Executive properly accounts
therefor.
ARTICLE V.
CONFIDENTIALITY
A. PROPRIETARY INFORMATION. Executive represents and warrants
that she has executed and delivered to the Company the Company's standard
Proprietary Information and Inventions Agreement in form acceptable to the
Company's counsel.
B. RETURN OF PROPERTY. All documents, records, apparatus,
equipment and other physical property which is furnished to or obtained by
Executive in the course of her employment with the Company shall be and remain
the sole property of the Company. Executive agrees that, upon the termination of
her employment, she shall return all such property (whether or not it pertains
to Proprietary Information as defined in the Proprietary Information and
Inventions Agreement), and agrees not to make or retain copies, reproductions or
summaries of any such property.
ARTICLE VI.
TERMINATION
A. BY DEATH. The period of employment shall terminate
automatically upon the death of Executive. In such event, the Company shall pay
to Executive's beneficiaries or her estate, as the case may be, any accrued Base
Salary, any bonus compensation to the extent earned, any vested deferred
compensation (other than pension plan or profit-sharing plan benefits which will
be paid in accordance with the applicable plan), any benefits under any plans of
the Company in which Executive is a participant to the full extent of
Executive's rights under such plans, any accrued vacation pay and any
appropriate business expenses incurred by Executive in connection with her
duties hereunder, all to the date of termination (collectively "Accrued
Compensation"), but no other compensation or reimbursement of any kind,
including, without limitation, severance compensation, and thereafter, the
Company's obligations hereunder shall terminate.
B. BY DISABILITY. If Executive is prevented from properly
performing her duties hereunder by reason of any physical or mental incapacity
for a period of more than 90 days in the aggregate in any 365-day period, then,
to the extent permitted by law, the Company may terminate the employment on the
90th day of such incapacity. In such event, the Company shall
-4
<PAGE>
pay to Executive all Accrued Compensation, and shall continue to pay to
Executive the Base Salary until such time (but not more than 90 days following
termination), as Executive shall become entitled to receive disability insurance
payments under the disability insurance policy maintained by the Company, which
disability policy shall provide for full payment of Executive's Base Salary
during the period of disability, but no other compensation or reimbursement of
any kind, including without limitation, severance compensation, and thereafter
the Company's obligations hereunder shall terminate. Nothing in this Section
shall affect Executive's rights under any disability plan in which she is a
participant.
C. BY COMPANY FOR CAUSE. The Company may terminate Executive's
employment for Cause (as defined below) without liability at any time with or
without advance notice to Executive. The Company shall pay Executive all Accrued
Compensation, but no other compensation or reimbursement of any kind, including
without limitation, severance compensation, and thereafter the Company's
obligations hereunder shall terminate. Termination shall be for "Cause" in the
event of the occurrence of any of the following: (a) any intentional action or
intentional failure to act by Executive which was performed in bad faith and to
the material detriment of the Company; (b) Executive intentionally refuses or
intentionally fails to act in accordance with any lawful and proper direction or
order of the Board; (c) Executive willfully and habitually neglects the duties
of employment; or (d) Executive is convicted of a felony crime involving moral
turpitude, provided that in the event that any of the foregoing events is
capable of being cured, the Company shall provide written notice to Executive
describing the nature of such event and Executive shall thereafter have five (5)
business days to cure such event.
D. AT WILL. At any time, the Company may terminate Executive's
employment without liability other than as set forth below, for any reason not
specified in Section 6.C above, by giving thirty (30) days advance written
notice to Executive. If the Company elects to terminate Executive pursuant to
this Section 6.D prior to a Change in Control, the Company shall pay to
Executive all Accrued Compensation and shall continue to pay to Executive as
provided herein Executive's Salary for six (6) months from the date of such
termination as severance compensation. If the Company or its successor elects to
terminate Executive pursuant to this Section after a Change in Control, the
Company (or its successor) shall continue to pay to Executive as provided herein
Executive's Salary for twelve (12) months from the date of such termination as
severance compensation. Upon payment of the severance benefits described herein,
all obligations of the Company (or its successor) shall terminate.
During the period when such severance compensation is being paid to
Executive, Executive shall not (i) engage, directly or indirectly, in any other
business activity that is competitive with, or that places him in a competing
position to that of the Company or any Affiliated Company (provided that
Executive may own less than two percent (2%) of the outstanding securities of
any publicly traded corporation), or (ii) hire, solicit, or attempt to hire on
behalf of herself or any other party any employee or exclusive consultant of the
Company. If the Company terminates this Agreement or the employment of Executive
with the Company other than pursuant to Section 6.A, 6.B or 6.C, then this
Section 6.D shall apply.
-5
<PAGE>
E. CONSTRUCTIVE TERMINATION. In the event that the Company
shall materially reduce the powers and duties of employment of Executive
resulting in a material decrease in the responsibilities of Executive which
are inconsistent with Executive acting as Vice President and Assistant
General Counsel of the Company, such action shall be deemed to be a
termination of employment of Executive without cause pursuant to Section 6.D.
In the event of a Change in Control of the Company in which the Company shall
become a division or subsidiary of a larger organization, references to the
Vice President and Assistant General Counsel of the Company shall be deemed
to mean the Vice President and Assistant General Counsel of such division or
subsidiary for purposes of this Section 6.E.
1. CHANGE IN CONTROL. For purposes of this Agreement, a "Change
in Control" shall have occurred if at any time during the term of Executive's
employment hereunder, any of the following events shall occur:
-6
<PAGE>
a. The consummation of a merger or consolidation of the Company
with or into another entity or any other corporate
reorganization, if more than 50% of the combined voting power
of the continuing or surviving entity's securities outstanding
immediately after such merger, consolidation or other
reorganization is owned by persons who were not stockholders
of the Company immediately prior to such merger, consolidation
or other reorganization;
b. A change in the composition of the Board, as a result of which
fewer than one-half of the incumbent directors are directors
who either (1) had been directors of the Company 24 months
prior to such change; or (2) were elected, or nominated for
election, to the Board with the affirmative votes of at least
a majority of the directors who had been directors of the
Company 24 months prior to such change and who were still in
office at the time of the election or nomination; or
c. Any "person" (as such term is used in Section 13(d) and
Section 14 of the Exchange Act) by the acquisition of
securities is or becomes the beneficial owner, directly or
indirectly, of securities of the Company representing 50% or
more of the combined voting power of the Company's then
outstanding securities ordinarily (and apart from rights
accruing under special circumstances) having the right to vote
at elections of directors (the "Base Capital Stock") except
that any change in the relative beneficial ownership of the
Company's securities resulting solely from a reduction in the
aggregate number of outstanding shares of Base Capital Stock ,
and any decrease thereafter in such person's ownership of
securities shall be disregarded until such person increases in
any manner, directly or indirectly, such person's beneficial
ownership of any securities of the Company. Thus, for example,
any person who owns less than 50% of the Company's outstanding
shares, shall cause a Change in Control to occur as of any
subsequent date if such person then acquires an additional
interest in the Company which, when added to the person's
previous holdings, causes the person to hold more than 50% of
the Company's outstanding shares.
The term "Change in Control" shall not include a transaction, the sole
purpose of which is to change the state of the Company's incorporation.
ARTICLE VII.
GENERAL PROVISIONS
A. GOVERNING LAW. The validity, interpretation, construction and
performance of this Agreement and the rights of the parties thereunder shall be
interpreted and enforced under California law without reference to principles of
conflicts of laws. The parties expressly agree that inasmuch as the Company's
headquarters and principal place of business are located in California, it is
appropriate that California law govern this Agreement.
-7
<PAGE>
B. ASSIGNMENT; SUCCESSORS; BINDING AGREEMENT.
1. Executive may not assign, pledge or encumber his interest in
this Agreement or any part thereof.
2. The Company will require any successor (whether direct or
indirect, by purchase, merger, consolidation or otherwise) to all or
substantially all of the business and/or assets of the Company, operation of law
or by agreement in form and substance reasonably satisfactory to Executive, to
assume and agree to perform this Agreement in the same manner and to the same
extent that the Company would be required to perform it if no such succession
had taken place.
3. This Agreement shall inure to the benefit of and be
enforceable by Executive's personal or legal representatives, executors,
administrators, successors, heirs, distributee, devisees and legatees. If
Executive should die while any amount is at such time payable to her hereunder,
all such amounts, unless otherwise provided herein, shall be paid in accordance
with the terms of this Agreement to Executive's devisee, legates or other
designee or, if there be no such designee, to her estate.
C. NO WAIVER OF BREACH. The waiver by any party of the breach of
any provision of this Agreement shall not be deemed to be a waiver of any
subsequent breach.
D. NOTICE. For the purposes of this Agreement, notices and all
other communications provided for in this Agreement shall be in writing and
shall be deemed to have been duly given when delivered or mailed by certified or
registered mail, return receipt requested, postage prepaid, addressed to the
respective addresses set forth below or to such other address as either party
may have furnished to the other in writing in accordance herewith, except that
notice of change of address shall be effective only upon receipt.
To the Company: Nanogen, Inc.
10398 Pacific Center Court
San Diego, CA 92121
Attn: Chief Executive Officer
To Executive: Vera P. Pardee, Esq.
c/o Nanogen, Inc.
10398 Pacific Center Court
San Diego, CA 92121
E. MODIFICATION; WAIVER; ENTIRE AGREEMENT. No provisions of this
Agreement may be modified, waived or discharged unless such waiver, modification
or discharge is agreed to in writing signed by Executive and such officer as may
be specifically designated by the Board of the Company. No waiver by either
party hereto at any time of any breach by the other party of, or compliance
with, any condition or provision of this Agreement to be performed by such other
party shall be deemed a waiver of similar or dissimilar provisions or conditions
at the
-8
<PAGE>
same or any prior or subsequent time. No agreements or representations, oral or
otherwise, express or implied, with respect to the subject matter hereof have
been made by either party which are not expressly set forth in this Agreement.
F. VALIDITY. The invalidity or unenforceability of any provision
of this Agreement shall not affect the validity or enforceability of any other
provision of this Agreement, which shall remain in full force and effect.
G. CONTROLLING DOCUMENT. This Agreement supersedes any and all
prior employment agreements between the Company and Executive, but does not
supersede any other agreements between Company and Executive, including but not
limited to, the Nanogen Inc. Restricted Stock Purchase Agreement, any stock
option agreements or common stock purchase agreements entered into pursuant to
the Company's 1997 Stock Incentive Plan, and the Nanogen Employees' Handbook and
Policies, except as expressly provided herein. In case of conflict between any
of the terms and conditions of this Agreement and the documents herein referred
to, the terms and conditions of this Agreement shall control.
H. EXECUTIVE ACKNOWLEDGMENT. Executive acknowledges (a) that she
has consulted with or has had the opportunity to consult with independent
counsel of her own choice concerning this Agreement, and has been advised to do
so by the Company, and (b) that she has read and understands the Agreement, is
fully aware of its legal effect, and has entered into it freely based on her own
judgment.
I. REMEDIES.
1. INJUNCTIVE RELIEF. The parties agree that the services to be
rendered by Executive hereunder are of a unique nature and that in the event of
any breach or threatened breach of any of the covenants contained herein, the
damage or imminent damage to the value and the goodwill of the Company's
business will be irreparable and extremely difficult to estimate, making any
remedy at law or in damages inadequate. Accordingly, the parties agree that the
Company shall be entitled to injunctive relief against Executive in the event of
any breach or threatened breach of any such provisions by Executive, in addition
to any other relief (including damages) available to the Company under this
Agreement or under law.
2. EXCLUSIVE. Both parties agree that the remedy specified in
Section 7.I.1 above is not exclusive of any other remedy for the breach by
Executive of the terms hereof.
J. COUNTERPARTS. This Agreement may be executed in one or more
counterparts, all of which taken together shall constitute one and the same
Agreement.
Executed by the parties as of the day and year first above written.
-9
<PAGE>
NANOGEN, INC.
/s/Howard C. Birndorf
------------------------
By Howard C. Birndorf
Chief Executive Officer
EXECUTIVE:
/s/Vera P. Pardee
------------------------
Vera P. Pardee, Esq.
-10